TUGRUL DEMIREL

Dr. TUGRUL DEMIREL

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2020 in Biotechnology & Biotechnological Equipment
Verified
Journal Article
Open access
TDTUGRUL DEMIREL
TUGRUL DEMIREL
IYIlhan Yaylim
Ilhan Yaylim
SESefika Arzu Ergen
Sefika Arzu Ergen
MGMustafa Kayihan Gunay
Mustafa Kayihan Gunay
YTYaman Tekant
Yaman Tekant
TITurgay Isbir
Turgay Isbir
Paraoxonase 1 (PON1) is a well recognised member of human endogeneous free radical scavenging systems and its polymorphism and enzyme activity are attributed to various different cancer formations. We aimed to study the Paraoxonase 1 (PON1) polymorphism and enzyme activity in colorectal cancer patients. Peripheral blood samples for DNA extraction were collected from 54 colorectal cancer patients and 85 healthy individuals. Polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques were used for determination of the PON1192 polymorphism. The frequency of AA genotype was greater than BB and AB genotypes in all groups (n:65 with 46.8%; n:15 with 10.8% and n:59 with 42.4%, respectively). In both tumor groups, PON activities were significantly lower than the control group (p < 0.05). The AA genotype was significantly more frequent than the AB and BB genotypes in colorectal cancer patients. Although the rectum cancer patients’ number is low in our study, we hypothesise that decreased enzyme activity of PON 1 related to 192 gene polymorphisms might have a role in the formation of an oxidative microenvironment for cancerous DNA damage which may tend to increase distally in the colon. Further studies considering the location and the stage of the colorectal tumors with more patients may put a broadly wider view on this polymorphism and enzyme activity with respect to cancer formation.

9 April 2025 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
TDTUGRUL DEMIREL
TUGRUL DEMIREL
UKUlku Korkmaz
Ulku Korkmaz
SUSurendra Ugale
Surendra Ugale
Background: Intractable diarrhea or excess weight loss associated with protein-energy malnutrition (PEM) can occur after Transit Bipartition (TB). This study evaluates the effect of transposing the alimentary limb to the proximal intestines. Methods: Between 2017 and 2024, ten patients with malnutrition and diarrhea underwent Gastro-Jejunal Ileal Interposition (GJIB) surgery after TB. We prospectively monitored protein-energy malnutrition postoperatively and retrospectively analyzed demographic data, laboratory findings, and anthropometric measurements. Gastric transit scintigraphy was performed on symptomatic and asymptomatic patients to evaluate gastric evacuation diversity between the pylorus and the gastro-ileostomy. Results: Ten patients (male/female, 6/4) were operated on. The preoperative mean age was 49.4 ± 9.19 years. The mean body mass index (BMI) was 22.19 ± 1.13 kg/m2, the mean excess BMI loss (%EBMIL) percentage was 123.26 ± 14.85%, and the total weight loss percentage (%TWL) was 42.35 ± 0.33. Eighty percent of food passed through the gastroileostomy in all patients. The mean follow-up period was 50.56 ± 57.28 months. Postoperatively, the mean BMI increased to 28.16 ± 2.2 kg/m2 (p = 0.001), %EBMIL decreased to 79.88 ± 21.53% (p = 0.001), and %TWL decreased to 27.31 ± 10.1. Albumin levels rose from a median of 2.1 mg/dl to an average of 3.8 ± 0.78 mg/dl (p = 0.001), and stool frequency decreased from 11.56 ± 0.71 to 2.1 ± 2.12 per day (p = 0.001). The excluded bowel length percentage (Exl.B%) decreased significantly from 72.4 ± 3.18% to 12.3 ± 1.99% after conversion (p = 0.005). All patients were diabetic before and had remission after TB. Glycemic control was preserved after the conversion, with a median HbA1c of 5.4% compared to 5.8% before conversion. Conclusions: GJIB may be a viable revision procedure for resolving PEM and related complications without compromising the metabolic benefits of the initial surgery on diabetes resolution by decreasing the Exl.B%. Graphical


Verified
Journal Article
Open access
PDF file
TDTUGRUL DEMIREL
TUGRUL DEMIREL
NSNecdet Sut
Necdet Sut
SUSurendra Ugale
Surendra Ugale
Background/Objectives: Gastrojejunal–ileal interposition with bipartition and sleeve gastrectomy (GJIB-SG) is a novel metabolic procedure developed to combine functional foregut exclusion with hindgut stimulation while preserving duodenal continuity and endoscopic biliary access. This study evaluated the medium-term glycemic, weight-loss, and nutritional safety outcomes of GJIB-SG in patients with obesity and long-standing type 2 diabetes (T2D). Methods: A retrospective single-center cohort of 30 consecutive patients with obesity and T2D who underwent GJIB-SG between January 2016 and August 2019 and reached at least 60 months of postoperative follow-up was analyzed at baseline and at 12, 24, 36, 48, and 60 months. Longitudinal data were analyzed by repeated-measures ANOVA with Greenhouse–Geisser correction and Bonferroni-adjusted pairwise comparisons. Diabetes remission was classified using the 2021 American Diabetes Association consensus definition (A1C < 6.5%, medication-free). Results: Mean body weight decreased from 102.4 ± 13.6 kg preoperatively to 73.5 ± 7.6 kg at 60 months (p < 0.001; mean %TWL 27.4%, mean %EWL 99.4%). Mean A1C decreased from 9.4 ± 1.6% to 6.0 ± 1.4% at 60 months (p < 0.001). Complete medication-free remission was achieved by 70.0% of patients at 12 months and 44.8% at 60 months; cumulatively, 25 of 30 (83.3%) achieved complete remission at one or more intervals, and 3 patients (10.0%) never achieved A1C < 6.5%. Triglycerides, total cholesterol, and LDL cholesterol decreased by 56%, 39%, and 35%, respectively. No protein–energy malnutrition or hypoalbuminemia occurred; however, a late rise in parathyroid hormone and a return of 25-OH vitamin D toward preoperative insufficient values by 60 months indicate the need for sustained micronutrient surveillance. One cardiovascular death at 24 months was not considered procedure related. Conclusions: In this single-center cohort, GJIB-SG was associated with durable weight loss, sustained glycemic improvement with cumulative complete remission in 83.3% of patients, and absence of severe nutritional complications over 60 months. Prospective comparative studies with longitudinal mixed-effects analysis are warranted to define the role of GJIB-SG within the metabolic–surgical armamentarium.

5 September 2023 in Hippocrates Medical Journal
Verified
Journal Article
Closed access
ZTZeliha Türkyilmaz
Zeliha Türkyilmaz
TDTUGRUL DEMIREL
TUGRUL DEMIREL
Amaç: Meme kanseri kadınlarda en sık görülen kanserdir. Meme kanserinin, luminal A, luminal B, cerbB2'den zengin tip, triple negatif moleküler subtipleri tanımlanmıştır. Bu çalışma moleküler subtipler ile enflamatuar belirteçler arasındaki ilişkiyi ortayı koymayı amaçlamıştır. Gereç ve Yöntemler: Ocak 2019 ve Nisan 2023 tarihleri arasında opere edilen meme kanseri hastaları değerlendirmeye alındı. Hastaların demografik özellikleri, patoji değerlendirmeleri, moleküler alt tipleri ve labaratuvar verileri toplandı. Hemogramdan Nötrofil/Lenfosit oranı (NLR), Trombosit/Lenfosit oranı (PLR) ve Sistemik Enflamatuvar Yanıt İndeksi (SIRI) hesaplandı. Moleküler alt tipler ile enflamatuar belirteçler arasında ilişki istatistiksel olarak değerlendirildi. Bulgular: Çalışmaya dahil edilen hastaların ortanca yaşı 56 idi. Hastaların %82,8'inde östrojen reseptörü (ER+), %61,3'ünde progesteron reseptörü (PR+) pozitif çıktı. En yaygın moleküler alt tip lümen A idi. Ki67 kesme değeri 14 olduğunda ER durumu arasında istatistiksel olarak anlamlı bir ilişki bulundu (p=0,047). Ki67 cut-off değeri 20 olarak alındığında hem ER ile (p=0,002), hem de PR ile istatistiksel olarak anlamlı ilişki (p=0,025) gözlendi. NLR ve PLR'nin ortanca değerleri sırasıyla 1,9 (aralık, 0,7:21,3) ve 123 (aralık, 53,3:252) idi. Sonuç: Meme kanseri alt tipleri ile inflamatuar belirteçler arasında anlamlı bir ilişki bulamadık. Ancak cerbB2 ile PLR ve SIRI arasında istatistiksel olarak anlamlı fark gösterme eğilimi dikkat çekiciydi (sırasıyla p=0.08, p=0.057).

4 June 2025 in Medical Bulletin of Haseki
Verified
Journal Article
Open access
PDF file
TDTUGRUL DEMIREL
TUGRUL DEMIREL
SUSurendra Ugale
Surendra Ugale
Clinical and Endoscopic Outcomes of De Meester Switch in Duodenogastric Alkaline Reflux Disease: A Retrospective Analysis with Mid-Term Follow-up - The Medical Bulletin of Haseki